$270-billion medical and consumer giant Johnson & Johnson is not a stranger when it comes to 3D printing in the medical space, having partnered with Organovo to study the viability of bioprinted human tissue for testing new medications. Now, as Johnson & Johnson Innovation kicks off a new set of partnerships with a focus on R&D and product development outside of the company, Johnson & Johnson has announced that they will be working with Carbon 3D to produce custom surgical devices.…
The original post Johnson & Johnson Taps Carbon 3D for Medical 3D Printing appeared first on 3D Printing Industry.